|
|
F Djouadi, C J Weinheimer, J E Saffitz, C Pitchford, J Bastin, F J Gonzalez, D P Kelly
J Clin Invest. 1998;
102(6):1083
doi:10.1172/JCI3949
Abstract |
Full text
| PDF
T
he peroxisome proliferator-activated receptor alpha (PPARalpha) is a nuclear receptor implicated in the control of cellular lipid utilization. To test the hypothesis that PPARalpha is activated as a component of the cellular lipid homeostatic response, the expression of PPARalpha target genes was characterized in response to a perturbation in cellular lipid oxidative flux caused by pharmacologic inhibition of mitochondrial fatty acid import. Inhibition of fatty acid oxidative flux caused a feedback induction of PPARalpha target genes encoding fatty acid oxidation enzymes in liver and heart. In mice lacking PPARalpha (PPARalpha-/-), inhibition of cellular fatty acid flux caused massive hepatic and cardiac lipid accumulation, hypoglycemia, and death in 100% of male, but only 25% of female PPARalpha-/- mice. The metabolic phenotype of male PPARalpha-/- mice was rescued by a 2-wk pretreatment with beta-estradiol. These results demonstrate a pivotal role for PPARalpha in lipid and glucose homeostasis in vivo and implicate estrogen signaling pathways in the regulation of cardiac and hepatic lipid metabolism.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(91)
| Title and authors |
Publication |
Year |
Sex differences in lipid metabolism and metabolic disease risk
Michael G. Sugiyama, Luis B. Agellon
|
Biochem. Cell Biol.
|
2012 |
Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia
Afaf K El-Ansary, Abir G Ben Bacha, Layla Y Al- Ayahdi
|
Lipids Health Dis
|
2011 |
New insights into the role of PPARs
Alexandra Montagner, Gianpaolo Rando, Gwendoline Degueurce, Nicolas Leuenberger, Liliane Michalik, Walter Wahli
|
Prostaglandins, Leukotrienes and Essential Fatty Acids
|
2011 |
Sex differences in nuclear receptor-regulated liver metabolic pathways
Gianpaolo Rando, Walter Wahli
|
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
|
2011 |
Fenofibrate administration does not affect muscle triglyceride concentration or insulin sensitivity in humans
Leigh Perreault, Bryan C. Bergman, Devon M. Hunerdosse, David J. Howard, Robert H. Eckel
|
Metabolism
|
2011 |
Sex and gender differences in myocardial hypertrophy and heart failure
Vera Regitz-Zagrosek, Ute Seeland
|
Wien Med Wochenschr
|
2011 |
Disruption of CD38 gene enhances cardiac functions by elevating serum testosterone in the male null mice
Lu Gan, Wei Jiang, Yun-Fei Xiao, Lin Deng, Lun-Da Gu, Zhi-Yun Guo, Zhi-Chao Zhou, Dan Wu, Hong-Bo Xin
|
Life Sciences
|
2011 |
Red Clover Extract Ameliorates Dyslipidemia in Streptozotocin-induced Diabetic C57BL/6 Mice by Activating Hepatic PPARĪ± : RED CLOVER EXTRACT AND DIABETIC DYSLIPIDEMIA
Longxin Qiu, Hong Ye, Limei Chen, Yamin Hong, Fojin Zhong, Tingting Zhang
|
Phytother. Res.
|
2011 |
Sexual dimorphism in cardiac triacylglyceride dynamics in mice on long term caloric restriction
Natasha H. Banke, Lin Yan, Kayla M. Pound, Sunil Dhar, Heather Reinhardt, Mariana S. De Lorenzo, Stephen F. Vatner, E. Douglas Lewandowski
|
Journal of Molecular and Cellular Cardiology
|
2011 |
Fulminant hepatic failure requiring liver transplantation in 22q13.3 deletion syndrome
Oliver Bartsch, Eberhard Schneider, Natalja Damatova, Roger Weis, Maria Tufano, Raffaele Iorio, Alischo Ahmed, Vera Beyer, Ulrich Zechner, Thomas Haaf
|
Am. J. Med. Genet.
|
2010 |
|
